Literature DB >> 18497679

Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.

Thomas W Hoffmann1, Jean-Michel Halimi, Mathias Büchler, Florence Velge-Roussel, Alain Goudeau, Azmi Al Najjar, Marie-Denise Boulanger, Tarik Sqalli Houssaini, Jean-Frédéric Marliere, Yvon Lebranchu, Christophe Baron.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) infection is associated with a significant rate of morbidity after organ transplantation. The genetic factors influencing its occurrence have been little investigated. IL-12 plays a crucial role in anti-infectious immune responses, especially by stimulating IFNgamma production. An A-to-C single nucleotide polymorphism (SNP) within the 3'-untranslated region of the IL-12p40 gene has been characterized and was reported to be both functionally and clinically relevant. However, the impact of this single nucleotide polymorphism on events after organ transplantation has never been reported.
METHODS: In this study, we investigated the impact of the 3'-untranslated region polymorphism on the occurrence of CMV infection in 469 kidney recipients transplanted at the University Hospital of Tours between 1995 and 2005. The polymorphism was genotyped using the restriction fragment length polymorphism method and CMV infection was determined by pp65 antigenemia.
RESULTS: Multifactorial Cox regression analysis demonstrated that the presence of the C allele was an independent risk factor for CMV infection (OR=1.52, P=0.043), the risk being even higher when study was restricted to patients with positive CMV serological status before the graft and who did not receive any CMV prophylaxis (OR=1.88, P=0.028).
CONCLUSIONS: This study identified a new genetic risk factor for CMV reactivation after kidney transplantation. The results of our study suggest that C carriers might especially benefit from CMV prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497679     DOI: 10.1097/TP.0b013e31816c7dc7

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Genetic factors influence serological measures of common infections.

Authors:  Rohina Rubicz; Charles T Leach; Ellen Kraig; Nikhil V Dhurandhar; Ravindranath Duggirala; John Blangero; Robert Yolken; Harald H H Göring
Journal:  Hum Hered       Date:  2011-10-11       Impact factor: 0.444

Review 2.  PharmGKB summary: cyclosporine and tacrolimus pathways.

Authors:  Julia M Barbarino; Christine E Staatz; Raman Venkataramanan; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2013-10       Impact factor: 2.089

Review 3.  Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

Authors:  Christine E Staatz; Lucy K Goodman; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

4.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

5.  Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?

Authors:  C Ekenberg; I P Lodding; N E Wareham; S S Sørensen; H Sengeløv; F Gustafsson; A Rasmussen; M Perch; J D Lundgren; M Helleberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-08       Impact factor: 3.267

Review 6.  Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors:  J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms.

Authors:  Carolina Martínez-Laperche; Ismael Buño; Miren Vallejo; Paula Muñiz; Mi Kwon; Laura Solán; Rebeca Bailén; Diego Carbonell; María Chicano; Julia Suárez-González; Pilar Catalán; José María Bellón; Juan Carlos Triviño; Nieves Dorado; David Gallardo; José Luis Díez-Martín; Natalia Ramírez
Journal:  Ann Hematol       Date:  2022-05-07       Impact factor: 4.030

8.  Cytokine gene polymorphism associations with congenital cytomegalovirus infection and sensorineural hearing loss.

Authors:  B Kasztelewicz; J Czech-Kowalska; B Lipka; B Milewska-Bobula; M K Borszewska-Kornacka; J Romańska; K Dzierżanowska-Fangrat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-13       Impact factor: 3.267

9.  Association between single nucleotide polymorphisms (SNPs) of IL1, IL12, IL28 and TLR4 and symptoms of congenital cytomegalovirus infection.

Authors:  Dominika Jedlińska-Pijanowska; Beata Kasztelewicz; Justyna Czech-Kowalska; Maciej Jaworski; Klaudia Charusta-Sienkiewicz; Anna Dobrzańska
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

Review 10.  Host Genetics of Cytomegalovirus Pathogenesis.

Authors:  Efe Sezgin; Ping An; Cheryl A Winkler
Journal:  Front Genet       Date:  2019-07-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.